These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J. Cancer Res; 2001 Mar 15; 61(6):2523-32. PubMed ID: 11289125 [Abstract] [Full Text] [Related]
4. [Clinical evaluation of serum level of NCC-ST-439 as a new tumor marker for colorectal diseases--fluctuation of serum NCC-ST-439 in patients with colorectal cancers before and after surgery]. Sakurai Y, Kodaira S, Teramoto T, Sugano K, Abe O, Ohtake H, Iri H. Gan To Kagaku Ryoho; 1989 Sep 15; 16(9):3205-12. PubMed ID: 2782914 [Abstract] [Full Text] [Related]
6. Tumor markers in staging and prognosis of colorectal carcinoma. Levy M, Visokai V, Lipska L, Topolcan O. Neoplasma; 2008 Sep 15; 55(2):138-42. PubMed ID: 18237252 [Abstract] [Full Text] [Related]
7. [Study on carbohydrate antigen NCC-ST-439 in breast cancer]. Suzuki S, Nihei M, Nomizu T, Watanabe T, Kimijima I, Tsuchiya A, Abe R. Nihon Gan Chiryo Gakkai Shi; 1990 May 20; 25(5):1019-26. PubMed ID: 2202768 [Abstract] [Full Text] [Related]
8. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P. Eur J Surg Oncol; 2005 Mar 20; 31(2):164-9. PubMed ID: 15698733 [Abstract] [Full Text] [Related]
9. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases. Kumar Y, Pinedo IR, Tapuria N, Zabron A, Davidson BR. Eur J Gastroenterol Hepatol; 2008 Oct 20; 20(10):1006-11. PubMed ID: 18787469 [Abstract] [Full Text] [Related]
10. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients]. Grotowski M, Maruszyński M, Piechota W. Pol Merkur Lekarski; 2001 Dec 20; 11(66):476-9. PubMed ID: 11899841 [Abstract] [Full Text] [Related]
13. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? Chen CC, Yang SH, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Chang SC. J Surg Res; 2005 Apr 20; 124(2):169-74. PubMed ID: 15820244 [Abstract] [Full Text] [Related]
17. [The expression of NCC-ST-439, a tumor marker, in human breast cancer patients]. Miyahara E, Toi M, Wada T, Yamada H, Osaki A, Yanagawa E, Toge T. Gan No Rinsho; 1990 Sep 20; 36(11):2023-6. PubMed ID: 2232168 [Abstract] [Full Text] [Related]
18. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence. Holubec L, Topolcan O, Pikner R, Pecen L, Vaclavickova J, Wirthova M, Molacek J, Stieber P, Holdenrieder S, Sen LH, Finek J. Anticancer Res; 2000 Sep 20; 20(6D):5237-44. PubMed ID: 11326702 [Abstract] [Full Text] [Related]
19. [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer]. Anzai K, Kurihara M, Izumi T. Nihon Gan Chiryo Gakkai Shi; 1990 Jul 20; 25(7):1437-47. PubMed ID: 2212836 [Abstract] [Full Text] [Related]